WA
RDY icon

WFG Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

WFG Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-775
Closed -$7K – 1688
2016
Q3 		$7K Buy
775
+5
+0.6% +$48 ﹤0.01% 1224
2016
Q2 		$8K Hold
770
– – ﹤0.01% 1148
2016
Q1 		$7K Hold
770
– – ﹤0.01% 1131
2015
Q4 		$7K Hold
770
– – ﹤0.01% 1164
2015
Q3 		$10K Buy
770
+5
+0.7% +$62 ﹤0.01% 1091
2015
Q2 		$8K Hold
765
– – ﹤0.01% 1251
2015
Q1 		$9K Hold
765
– – ﹤0.01% 1240
2014
Q4 		$8K Hold
765
– – ﹤0.01% 1530
2014
Q3 		$8K Buy
765
+5
+0.7% +$47 ﹤0.01% 1557
2014
Q2 		$7K Hold
760
– – ﹤0.01% 1580
2014
Q1 		$7K Hold
760
– – ﹤0.01% 1552
2013
Q4 		$6K Hold
760
– – ﹤0.01% 1719
2013
Q3 		$6K Buy
760
+5
+0.7% +$36 ﹤0.01% 1683
2013
Q2 		$6K Buy
+755
New +$5.51K ﹤0.01% 1615

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

WFG Advisors's RDY Position: Q4 2016 in Review

WFG Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q4 2016, closing a stake of 775 shares — an estimated $7K sold.

WFG Advisors first reported a position in RDY in Q2 2013 and held it in 14 quarters. The position peaked at $10K in Q3 2015. 164 funds tracked by Wall St. Rank hold RDY as of Q4 2016.

  • WFG Advisors reported no remaining Dr. Reddy's Laboratories position as of Q4 2016 after selling out during the quarter.
  • WFG Advisors sold 775 Dr. Reddy's Laboratories shares in Q4 2016, an estimated $7K.
  • WFG Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 14 quarters.
  • WFG Advisors's Dr. Reddy's Laboratories position peaked at $10K in Q3 2015.
  • 164 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2016.

Based on WFG Advisors's 13F filing for Q4 2016, filed 1 Mar 2017.